Martina H Slingsby

Martina H Slingsby, PhD is a Senior Scientist at Alnylam Pharmaceuticals, leading the identification, validation, and development of new liver-targeting siRNA Drug Candidates. Martina H has extensive experience in preclinical project management, patent inventions, and collaboration with clinical development teams. Previously, Martina H held research fellow positions at Harvard Medical School, University of Copenhagen, and William Harvey Research Institute, focusing on platelet function and antiplatelet therapies. Martina also has experience in primary and secondary research in the pharmaceutical industry through an internship at Deallus Group. Martina H holds a PhD in Pharmacology from Imperial College London and a BSc in Pharmacology from UCL.